APLS

Apellis Pharmaceuticals Stock Price

46.47
1.71 (3.82%)
Upgrade to Real-Time
Afterhours (Closed)
46.47

Low
25.49

52 Week Range

High
58.47

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Apellis Pharmaceuticals Inc APLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.71 3.82% 46.47 19:30:47
Open Price Low Price High Price Close Price Prev Close
47.70 44.615 47.92 45.57 44.76
Bid Price Ask Price Spread News
45.57 46.49 0.92 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,916 808,638 $ 46.28 $ 37,427,419 769,474 25.49 - 58.47
Last Trade Time Type Quantity Stock Price Currency
19:57:21 6 $ 46.49 USD

Apellis Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.52B 75.74M 49.43M $ - $ - -5.20 -5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Apellis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week41.5547.9240.531142.71696,2604.9211.84%
1 Month43.9947.9239.9542.47722,9102.485.64%
3 Months47.5152.2639.9544.88644,346-1.04-2.19%
6 Months35.4858.4730.1445.95659,53410.9930.98%
1 Year31.8658.4725.4938.19706,47714.6145.86%
3 Years26.9058.4711.4531.92624,43119.5772.75%
5 Years14.5058.4711.4531.46567,03531.97220.48%

Apellis Pharmaceuticals Description

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.


Your Recent History
NASDAQ
APLS
Apellis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.